Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MDG 1021

Next Previous
Drug Profile

MDG 1021

Alternative Names: HA-1-specific T cell receptor therapy; MDG-1021

Latest Information Update: 19 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Leiden University Medical Center
  • Developer Leiden University Medical Center; MediGene AG
  • Class Antineoplastics; Gene therapies; Immunotherapies; T lymphocyte cell therapies
  • Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Haematological malignancies; Solid tumours

Most Recent Events

  • 30 Sep 2021 Medigene withdraws a phase I trial in Haematological malignancies (Second-line therapy or greater) in Netherlands before enrolment due to transfer of rights of MDG 1021 to Miltenyi Biotec (IV) (NCT04464889)
  • 01 Jul 2021 Medigene transfers rights related to MDG 1021 to Miltenyi Biotec
  • 16 May 2021 MDG 1021 is available for licensing as of 11 May 2021

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top